Onward Medical NVONWRF 37 Days Payable is 591.34 as of Dec. 2025, which is 181% above its 10-year median of 210.37. GuruFocus rates ONWRF with a GF Score™ of 37/100 and a GF Value™ of $154.42 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 705 Biotechnology companies, Onward Medical NV ranks better than 83.83% on this metric.
The historical rank and industry rank for Onward Medical NV's Days Payable or its related term are showing as below:
ONWRF'
s Days Payable Range Over the Past 10 Years
Min: 28.38 Med: 210.37 Max: 21883.41
Current: 764.9
During the past 9 years, Onward Medical NV's highest Days Payable was 21883.41. The lowest was 28.38. And the median was 210.37.
ONWRF's Days Payable is ranked better than 83.83% of 705
companies
in the Biotechnology industry
Industry Median: 113.36
vs ONWRF: 764.90
Onward Medical NV's Days Payable
declined
from Dec. 2024 (19,416.41) to Dec. 2025 (591.34).
It may suggest that Onward Medical NVaccelerated paying its suppliers.
Onward Medical NV Days Payable Related Terms
Onward Medical NV Days Payable Historical Data
* Premium members only.
The historical data trend for Onward Medical NV's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ONWRF vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Onward Medical NV's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Onward Medical NV Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Onward Medical NV's Days Payable distribution charts can be found below:
* The bar in red indicates where Onward Medical NV's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Onward Medical NV's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Onward Medical NV (ONWRF) has a Days Payable of 591.34 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Onward Medical NV and its competitors. This is 181% above median its historical median of 210.37. Over the past decade, Onward Medical NV's Days Payable has ranged from 28.38 to 21,883.41. According to the industry distribution chart, Onward Medical NV ranks #114 out of 705 companies in the Biotechnology industry, placing it in the top 16.2%.
Is Onward Medical NV's Days Payable too high?
Onward Medical NV's current Days Payable of 591.34 is 181% above median its 10-year median of 210.37. Over the past 10 years, this metric has ranged from a low of 28.38 to a high of 21,883.41. The Biotechnology industry median Days Payable is 113.36. Onward Medical NV's value of 591.34 is 421.6% above this industry median. Based on the distribution chart, Onward Medical NV ranks #114 out of 705 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Onward Medical NV has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Onward Medical NV's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Onward Medical NV ranks #114 out of 705 companies for Days Payable. This places Onward Medical NV in the top 16% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.36. Onward Medical NV's value of 591.34 is 421.6% above this benchmark. Historically, Onward Medical NV's own Days Payable has ranged from 28.38 to 21,883.41 over the past decade. While the company's 10-year median is 210.37 vs. the industry median of 113.36, Onward Medical NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.36, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onward Medical NV's current Days Payable of 591.34 is 421.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Onward Medical NV and its competitors. For the Biotechnology industry, the median Days Payable is 113.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onward Medical NV's current Days Payable is 591.34, which is 181% above median its own 10-year median of 210.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onward Medical NV stock overvalued right now?
Based on GuruFocus' analysis, Onward Medical NV (ONWRF) is currently considered Possible Value Trap. The stock's GF Value™ is $154.42, compared to a current price of $2.96 — trading 98.1% below its estimated fair value. The current Days Payable is 591.34, which is 181% above median its 10-year median of 210.37 and 421.6% above the Biotechnology industry median of 113.36. Onward Medical NV's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Onward Medical NV (ONWRF), the current Days Payable is 591.34 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Onward Medical NV (ONWRF) Overvalued in 2026?
Based on GuruFocus' analysis, Onward Medical NV stock appears to be undervalued.
The current stock price of $2.96 is trading 98.1% below its estimated GF Value™ of $154.42.
GuruFocus considers Onward Medical NV to be Possible Value Trap.
Key valuation signals for ONWRF:
Days Payable: 591.34 (181% above median its 10-year median of 210.37)
GF Value™: $154.42 vs. price of $2.96 (98.1% below fair value)
Industry Position: 421.6% above the Biotechnology median (#114 of 705)
No single metric tells the full story. See the ONWRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Onward Medical NV is developing and commercializing therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company's technology platforms are based on ONWARD ARC Therapy (ARC Therapy), targeted, programmed electrical stimulation of the spinal cord designed to restore movement, independence, and health in people with SCI.
37GF Score
Get the complete analysis for ONWRF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ONWRF has been successfully added to your 
